Lv6
2730 积分 2023-06-25 加入
POS0656 TOLERABILITY AND EFFICACY OF BMS-986353 (CC-97540), A CD19-DIRECTED CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL THERAPY MANUFACTURED USING A NEXT-GENERATION PROCESS FOR SYSTEMIC SCLEROSIS: UPDATED DATA FROM THE PHASE 1 BREAKFREE-1 STUDY
2个月前
已完结
Polypoidal Choroidal Vasculopathy: Updates on Risk Factors, Diagnosis, and Treatments
8个月前
已完结
Review on classification of polypoidal choroidal vasculopathy
8个月前
已完结
Polypoidal Choroidal Vasculopathy
8个月前
已完结
Consensus and guidelines on diagnosis and management of polypoidal choroidal vasculopathy (PCV) from the Asia-Pacific Vitreo-retina Society (APVRS)
8个月前
已完结
皖公网安备34019202002308
